Validity of the DSM‐5 anxious distress specifier for major depressive disorder

M Zimmerman, J Martin, P McGonigal… - Depression and …, 2019 - Wiley Online Library
Background DSM‐5 introduced the anxious distress specifier in recognition of the clinical
significance of anxiety in depressed patients. Recent studies that supported the validity of …

Anxious distress in people with major depressive episodes: a cross-sectional analysis of clinical correlates

F Bartoli, B Bachi, T Callovini, D Palpella, S Piacenti… - CNS …, 2024 - cambridge.org
ObjectiveMost people with major depressive episodes meet the criteria for the anxious
distress (AD) specifier defined by DSM-5 as the presence of symptoms such as feelings of …

Comorbidity with more anxiety disorders associated with a poorer prognosis persisting at the 10-year follow-up among patients with major depressive disorder

CI Hung, CY Liu, CH Yang, ST Gan - Journal of Affective Disorders, 2020 - Elsevier
Objective No study has investigated the association between number of anxiety disorders
(NADs) and long-term outcome over 10 years among patients with major depressive …

A comparison of the dimensionality of the Hamilton Rating Scale for anxiety and the DSM-5 Anxious-Distress Specifier Interview

C Rodriguez-Seijas, JS Thompson, JM Diehl… - Psychiatry …, 2020 - Elsevier
Abstract The Hamilton Rating Scale for Anxiety (HAM-A) is one of the most widely used
measures for assessing anxiety in research settings. However, it has been criticized for its …

What is anxious depression? Overlap and agreement between different definitions

M Zimmerman, S Kerr, R Kiefer, C Balling… - Journal of psychiatric …, 2019 - Elsevier
Anxiety is common in depressed patients. However, a problem with the research on the
significance of anxiety in depressed patients is that anxiety has been characterized in …

Neural correlates of anxious distress in depression: A neuroimaging study of reactivity to emotional faces and resting‐state functional connectivity

L Nawijn, R Dinga, M Aghajani, MJ van Tol… - Depression and …, 2022 - Wiley Online Library
Background Comorbid anxiety disorders and anxious distress are highly prevalent in major
depressive disorder (MDD). The presence of the DSM‐5 anxious distress specifier (ADS) …

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies

ME Thase, E Weiller, P Zhang, C Weiss… - Neuropsychiatric …, 2018 - Taylor & Francis
Objective Episodes of major depressive disorder (MDD) characterized by high levels of
anxiety symptoms are less likely to respond to some forms of antidepressant treatment …

Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: an iSPOT-D report

TA Braund, DM Palmer, LM Williams… - Australian & New …, 2019 - journals.sagepub.com
Objective: Major depressive disorder commonly co-occurs with one or more anxiety
disorders or with clinically significant levels of anxiety symptoms. Although evidence …

Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity

GJ Lyndon, R Prieto, DB Wajsbrot… - International clinical …, 2019 - journals.lww.com
Abstract Effects of baseline anxiety on the efficacy of venlafaxine extended release versus
placebo were examined in a post hoc pooled subgroup analysis of 1573 patients enrolled in …

A data-driven classification of outcome behaviors in those who cause concern to British public figures.

C Clemmow, P Gill, E Corner, F Farnham… - … , Public Policy, and …, 2021 - psycnet.apa.org
Fixated individuals pose a significant threat to public figures. Previous research compares
individuals labeled 'approachers' to those labeled 'communicators.'Typically, such studies …